NCT05979012

Brief Summary

Chronic pain, including spinal pain and osteoarthritis, is the leading cause of years lived with disability world-wide and the costliest health condition in the U.S. today. Compounding these concerns, opioid analgesics remain the primary pharmacological treatment for chronic pain. An estimated 21-29% of chronic pain patients receiving long-term opioid therapy develop opioid misuse, and opioid misuse portends addiction and overdose. Clearly, chronic pain patients need better, non-addictive treatment options designed to reverse the downward spiral of chronic pain.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable chronic-pain

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 7, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

2.7 years

First QC Date

July 28, 2023

Last Update Submit

January 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity portion of The Pain, Enjoyment of Life and General Activity (PEG) scale

    The Pain, Enjoyment of Life and General Activity (PEG) scale will be used to assess the magnitude of pain sensations experienced by participants in the past week. Range 0-10, where higher score equals more pain.

    4 weeks

Study Arms (3)

Jazz Only

ACTIVE COMPARATOR

Jazz Group 1: Participants in this group will watch an introduction to jazz appreciation video prior to the 4-week intervention.

Behavioral: Listening to Jazz

MIndfullness and Jazz

EXPERIMENTAL

Jazz Group 2 (Mindful Jazz) Group: Participants in this group will watch an introduction to jazz appreciation and mindfulness training video, including the use of jazz for pain tolerance prior to the 4-week intervention.

Behavioral: MIndfulness Listening to Jazz

Waitlist

NO INTERVENTION

Music Waitlist Group: Participants in this group will serve as a control and will not receive any intervention until the study is completed. They will complete a baseline survey and a follow-up survey at four weeks. Some videos will be sent to this group after the study is completed, without tracking their usage.

Interventions

All groups will complete a baseline and 4-week follow-up survey. Participants in Jazz Group 1 and Jazz Group 2 will engage in daily listening 4-week intervention.It is up to them if they want to listen to the daily recordings.

MIndfullness and Jazz

All groups will complete a baseline and 4-week follow-up survey. Participants in Jazz Group 1 and Jazz Group 2 will engage in daily listening 4-week intervention.They will have access to electronic audio recordings, with the order of listening labeled for each day. The recordings will increase gradually throughout the study, starting with about 10 minutes each day in the first week and reaching 30 minutes each day in the final week. The schedule is as follows: Week 1= 10 minutes, Week 2= 15 minutes, Week 3= 20 minutes Week 4= 30 minutes. It is up to them if they want to listen to the daily recordings.

Jazz Only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Are 18+
  • Live in the US
  • Are an English-proficient adult with a chronic pain diagnosis (no restrictions placed on type)
  • Have a pain rating of four or greater in average pain on a 0-10 numeric rating scale in the preceding week
  • Have had pain for at least 3 months and for at least 15 days in the preceding 30 days
  • Have moderate to severe anxiety based on GAD-7

You may not qualify if:

  • Are currently using or have used prescription opioids in the past 3 months to minimize a known treatment confound and increase sample homogeneity
  • Have a current cancer diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California Irvine

Irvine, California, 92868, United States

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 7, 2023

Study Start

August 1, 2023

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

February 2, 2026

Record last verified: 2026-01

Locations